Can an FDA-approved drug help halt vision loss in MS?
Final date to apply is Feb. 1
“OMRF has saved my life,” says MS patient Tonja Martin.
The Lupus Research Alliance is the world’s leading private funder of lupus research.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.